AMGN
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F2833235&ei=n4aaUvD9OdO60AGuJw&usg=AFQjCNHsctdRSwI4jtqaoXqCKRV2cYJyaw
Amgen Inc and Onyx Pharmaceuticals Inc Announces Early Termination of HSR Waiting Period For Amgen's Acquisition of Onyx Pharmaceuticals
Wednesday, 18 Sep 2013 05:45pm EDT
Amgen Inc and Onyx Pharmaceuticals Inc announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Amgen's proposed acquisition of Onyx, was terminated early on September 18, 2013, by the United States Federal Trade Commission. The waiting period was scheduled to expire on September 23, 2013.Â 
